查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612205

主动脉瘤市场：按类型、产品、治疗、最终用途分类 - 全球预测 2025-2030

Aortic Aneurysm Market by Type (Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm), Product (Catheters, Stent Grafts), Treatment, End-use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年主动脉瘤市值为44.3亿美元，预计到2024年将达到47.9亿美元，复合年增长率为8.65%，到2030年将达到79.2亿美元。

主动脉瘤是主动脉的局部扩大，主动脉是将血液从心臟输送到身体其他部位的主要动脉。主动脉诊断和治疗市场受到心血管疾病盛行率上升和全球人口老化的推动，全球人口变得更容易罹患此类疾病。此外，先进影像处理技术和外科手术（例如血管内动脉瘤修復术（EVAR））的日益普及正在扩大医院和专科诊所的应用范围和最终用途。市场成长主要由诊断工具的技术进步、早期检测重要性的意识计划以及政府措施推动。然而，主要挑战包括治疗费用高昂、贫困地区获得医疗保健的机会有限以及对熟练医疗专业人员的需求。主要的成长机会包括开发更具成本效益的诊断解决方案和微创手术选择，这可以减少復原时间和医疗成本，同时惠及更广泛的人。创新是生物技术和资料分析的交叉点，研究重点是遗传标记和人工智慧，以更准确地预测动脉瘤的形成和进展。开发人员应寻求与高科技公司合作，开发人工智慧诊断和个人化治疗计划。然而，应对监管复杂性至关重要，因为合规性可确保安全性和有效性标准。儘管存在这些障碍，市场仍可以从数位医疗服务的扩展中受益，该服务可以透过对主动脉瘤患者进行远端监控和检查来解决一些存取问题。总而言之，儘管主动脉瘤市场面临高治疗成本和监管挑战等限制，但人工智慧和生物技术领域的重点研究和策略联盟可以为 Masu 的重大进步铺平道路。这种方法不仅有望改善患者的治疗效果，而且使公司处于心血管医疗保健创新的前沿。

主要市场统计
基准年[2023] 44.3亿美元
预测年份 [2024] 47.9亿美元
预测年份 [2030] 79.2亿美元
复合年增长率（%） 8.65%

市场动态：揭示快速发展的主动脉瘤市场的关键市场洞察

主动脉瘤市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 老化社会主动脉瘤发生率增加
    • 加强宣传宣传活动并定期筛检高风险族群
  • 市场限制因素
    • 产品召回增加
  • 市场机会
    • 医学影像和微创手术技术的进步
    • 医疗机构合作
  • 市场挑战
    • 对主动脉瘤手术期间和术后併发症的担忧

波特五力：主动脉瘤市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解主动脉瘤市场的外部影响

外部宏观环境因素在塑造主动脉瘤市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解主动脉瘤市场的竞争状况

主动脉瘤市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵主动脉瘤市场供应商绩效评估

FPNV定位矩阵是评估主动脉瘤市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了主动脉瘤市场的成功之路

主动脉瘤市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 老化社会主动脉瘤发生率增加
      • 加强宣传宣传活动并定期对高危险群进行检测
    • 抑制因素
      • 产品回收数量增加
    • 机会
      • 医学影像和微创手术技术的进步
      • 医疗机构间合作
    • 任务
      • 对主动脉瘤手术期间和术后併发症的担忧
  • 市场区隔分析
    • 类型：腹主动脉瘤（AAA）在患有高血压的老年人中越来越多。
    • 最终用途：医院严重主动脉瘤管理和治疗的演变
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章主动脉瘤市场：依类型

  • 腹部主动脉血管瘤
  • 胸主动脉瘤

第七章主动脉瘤市场：副产品

  • 导管
  • 血管支架

第八章主动脉瘤市场（依治疗）

  • 动脉瘤血管内修復术
  • 透过开放性手术修復

第九章主动脉瘤市场：依最终用途分类

  • 门诊手术中心
  • 诊所
  • 医院

第10章北美和南美的主动脉瘤市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太主动脉瘤市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的主动脉瘤市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 加州大学戴维斯分校健康中心开始地区首个使用创新微创主动脉装置的临床试验
    • FDA核准用于先进治疗的新型戈尔设备，宣布推出 TAMBE 内置假体消除设备
    • Nectero Medical 开始创新主动脉瘤治疗的关键临床试验
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Altura Medical Inc.
  • Artivion, Inc.
  • Bentley InnoMed GmbH
  • Bolton Medical, Inc.
  • Boston Scientific Corporation
  • Cardinal Health company
  • Cook Medical Inc.
  • CryoLife, Inc.
  • Endologix Inc.
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips NV
  • Lemaitre Vascular Inc.
  • LifeTech Scientific Corporation
  • LivaNova PLC
  • Lombard Medical, Inc.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Phenox GmbH
  • Terumo Corporation
  • WL Gore & Associates, Inc.
Product Code: MRR-D1342F184FD2

The Aortic Aneurysm Market was valued at USD 4.43 billion in 2023, expected to reach USD 4.79 billion in 2024, and is projected to grow at a CAGR of 8.65%, to USD 7.92 billion by 2030.

An aortic aneurysm is a localized enlargement of the aorta, the main artery carrying blood from the heart to the rest of the body. The market for its diagnosis and treatment is driven by the rising prevalence of cardiovascular diseases and an aging global population more susceptible to such conditions. Additionally, the increasing availability of advanced imaging technologies and surgical procedures, such as endovascular aneurysm repair (EVAR), expands the application and end-use scope across hospitals and specialty clinics. Market growth is primarily fueled by technological advancements in diagnostic tools, awareness programs about the importance of early detection, and government initiatives. However, the high costs associated with treatment, limited healthcare access in underprivileged regions, and the need for skilled healthcare professionals pose significant challenges. Key growth opportunities include the development of more cost-effective diagnostic solutions and minimally invasive surgical options, which would cater to a broader demographic while reducing recovery time and healthcare costs. Innovation lies at the intersection of biotechnology and data analytics, with research focused on genetic markers and artificial intelligence to predict aneurysm formation and progression more accurately. Businesses should explore partnerships with tech companies to develop AI-powered diagnostics and personalized treatment plans. However, navigating regulatory complexities is crucial, as compliance ensures safety and efficacy standards. Despite these hurdles, the market can benefit from expanding digital healthcare services, enabling remote monitoring and consultation for aortic aneurysm patients, thereby addressing some access issues. In conclusion, while the aortic aneurysm market faces limitations like high treatment costs and regulatory challenges, focused research and strategic collaborations in AI and biotechnology can pave the way for significant advancements. This approach not only promises better patient outcomes but also positions companies at the forefront of innovation in cardiovascular healthcare.

KEY MARKET STATISTICS
Base Year [2023] USD 4.43 billion
Estimated Year [2024] USD 4.79 billion
Forecast Year [2030] USD 7.92 billion
CAGR (%) 8.65%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Aortic Aneurysm Market

The Aortic Aneurysm Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of aortic aneurysms among aging population
    • Rise in awareness campaigns and routine screenings for at-risk populations
  • Market Restraints
    • Rising incidences of product recalls
  • Market Opportunities
    • Advances in medical imaging technology and minimally invasive surgical techniques
    • Collaborations between medical institutions
  • Market Challenges
    • Concerns over complications during and after surgery of aortic aneurysms

Porter's Five Forces: A Strategic Tool for Navigating the Aortic Aneurysm Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Aortic Aneurysm Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Aortic Aneurysm Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Aortic Aneurysm Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Aortic Aneurysm Market

A detailed market share analysis in the Aortic Aneurysm Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Aortic Aneurysm Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Aortic Aneurysm Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Aortic Aneurysm Market

A strategic analysis of the Aortic Aneurysm Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Aortic Aneurysm Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Altura Medical Inc., Artivion, Inc., Bentley InnoMed GmbH, Bolton Medical, Inc., Boston Scientific Corporation, Cardinal Health company, Cook Medical Inc., CryoLife, Inc., Endologix Inc., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Lemaitre Vascular Inc., LifeTech Scientific Corporation, LivaNova PLC, Lombard Medical, Inc., Medtronic PLC, MicroPort Scientific Corporation, Phenox GmbH, Terumo Corporation, and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Aortic Aneurysm Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Abdominal Aortic Aneurysm and Thoracic Aortic Aneurysm.
  • Based on Product, market is studied across Catheters and Stent Grafts.
  • Based on Treatment, market is studied across Endovascular Aneurysm Repair and Open Surgical Repair.
  • Based on End-use, market is studied across Ambulatory Surgery Centers, Clinic, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of aortic aneurysms among aging population
      • 5.1.1.2. Rise in awareness campaigns and routine screenings for at-risk populations
    • 5.1.2. Restraints
      • 5.1.2.1. Rising incidences of product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Advances in medical imaging technology and minimally invasive surgical techniques
      • 5.1.3.2. Collaborations between medical institutions
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns over complications during and after surgery of aortic aneurysms
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing cases of abdominal aortic aneurysm (AAA) found in older individuals with high blood pressure
    • 5.2.2. End-use: Evolving management and treatment of severe cases of aortic aneurysms in the hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Aortic Aneurysm Market, by Type

  • 6.1. Introduction
  • 6.2. Abdominal Aortic Aneurysm
  • 6.3. Thoracic Aortic Aneurysm

7. Aortic Aneurysm Market, by Product

  • 7.1. Introduction
  • 7.2. Catheters
  • 7.3. Stent Grafts

8. Aortic Aneurysm Market, by Treatment

  • 8.1. Introduction
  • 8.2. Endovascular Aneurysm Repair
  • 8.3. Open Surgical Repair

9. Aortic Aneurysm Market, by End-use

  • 9.1. Introduction
  • 9.2. Ambulatory Surgery Centers
  • 9.3. Clinic
  • 9.4. Hospitals

10. Americas Aortic Aneurysm Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Aortic Aneurysm Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Aortic Aneurysm Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. UC Davis Health Initiates Regional First in Clinical Trial Using Innovative, Less Invasive Aortic Device
    • 13.3.2. FDA Approves New Gore Device for Advanced Aortic Aneurysm Treatment, Introducing the Excluder TAMBE Endoprosthesis
    • 13.3.3. Nectero Medical Launches Pivotal Clinical Trial for Innovative Aortic Aneurysm Treatment
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Altura Medical Inc.
  • 3. Artivion, Inc.
  • 4. Bentley InnoMed GmbH
  • 5. Bolton Medical, Inc.
  • 6. Boston Scientific Corporation
  • 7. Cardinal Health company
  • 8. Cook Medical Inc.
  • 9. CryoLife, Inc.
  • 10. Endologix Inc.
  • 11. Johnson & Johnson Services, Inc.
  • 12. Koninklijke Philips N.V.
  • 13. Lemaitre Vascular Inc.
  • 14. LifeTech Scientific Corporation
  • 15. LivaNova PLC
  • 16. Lombard Medical, Inc.
  • 17. Medtronic PLC
  • 18. MicroPort Scientific Corporation
  • 19. Phenox GmbH
  • 20. Terumo Corporation
  • 21. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. AORTIC ANEURYSM MARKET RESEARCH PROCESS
  • FIGURE 2. AORTIC ANEURYSM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AORTIC ANEURYSM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. AORTIC ANEURYSM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. AORTIC ANEURYSM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AORTIC ANEURYSM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AORTIC ANEURYSM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. AORTIC ANEURYSM MARKET DYNAMICS
  • TABLE 7. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR ANEURYSM REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 188. AORTIC ANEURYSM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 189. AORTIC ANEURYSM MARKET, FPNV POSITIONING MATRIX, 2023